These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16937007)

  • 41. Effect of apelin-apelin receptor system in postischaemic myocardial protection: a pharmacological postconditioning tool?
    Rastaldo R; Cappello S; Folino A; Losano G
    Antioxid Redox Signal; 2011 Mar; 14(5):909-22. PubMed ID: 20615122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ac2-26 Mimetic Peptide of Annexin A1 Inhibits Local and Systemic Inflammatory Processes Induced by Bothrops moojeni Venom and the Lys-49 Phospholipase A2 in a Rat Model.
    Stuqui B; de Paula-Silva M; Carlos CP; Ullah A; Arni RK; Gil CD; Oliani SM
    PLoS One; 2015; 10(7):e0130803. PubMed ID: 26147724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The role of free radicals in the myocardial reperfusion injuries and in the development of endogenous adaptation].
    Rőth E
    Orv Hetil; 2015 Nov; 156(47):1908-11. PubMed ID: 26568105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The anti-inflammatory Annexin A1 induces the clearance and degradation of the amyloid-β peptide.
    Ries M; Loiola R; Shah UN; Gentleman SM; Solito E; Sastre M
    J Neuroinflammation; 2016 Sep; 13(1):234. PubMed ID: 27590054
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The essential role of annexin A1 mimetic peptide in the skin allograft survival.
    Teixeira RA; Mimura KK; Araujo LP; Greco KV; Oliani SM
    J Tissue Eng Regen Med; 2016 Feb; 10(2):E44-53. PubMed ID: 23897745
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Annexin 1-derived peptide Ac2-26 inhibits eosinophil recruitment in vivo via decreasing prostaglandin D₂.
    Wang LM; Li WH; Xu YC; Wei Q; Zhao H; Jiang XF
    Int Arch Allergy Immunol; 2011; 154(2):137-48. PubMed ID: 20733322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rationale and design of the 'F.I.R.E.' study. A multicenter, double-blind, randomized, placebo-controlled study to measure the effect of FX06 (a fibrin-derived peptide Bbeta(15-42)) on ischemia-reperfusion injury in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Atar D; Huber K; Rupprecht HJ; Kopecky SL; Schwitter J; Theek C; Brandl K; Henning R; Geudelin B
    Cardiology; 2007; 108(2):117-23. PubMed ID: 17019083
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A role for MC3R in modulating lung inflammation.
    Getting SJ; Riffo-Vasquez Y; Pitchford S; Kaneva M; Grieco P; Page CP; Perretti M; Spina D
    Pulm Pharmacol Ther; 2008 Dec; 21(6):866-73. PubMed ID: 18992358
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Annexin-1 Mediates Microglial Activation and Migration via the CK2 Pathway during Oxygen-Glucose Deprivation/Reperfusion.
    Liu S; Gao Y; Yu X; Zhao B; Liu L; Zhao Y; Luo Z; Shi J
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27782092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Parstatin(1-26): the putative signal peptide of protease-activated receptor 1 confers potent protection from myocardial ischemia-reperfusion injury.
    Routhu KV; Tsopanoglou NE; Strande JL
    J Pharmacol Exp Ther; 2010 Mar; 332(3):898-905. PubMed ID: 20008957
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of pro-invasive mechanisms and N-terminal cleavage of ANXA1 in melanoma.
    Boudhraa Z; Merle C; Mazzocut D; Chezal JM; Chambon C; Miot-Noirault E; Theisen M; Bouchon B; Degoul F
    Arch Dermatol Res; 2014 Dec; 306(10):903-14. PubMed ID: 25362540
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor.
    Dalli J; Consalvo AP; Ray V; Di Filippo C; D'Amico M; Mehta N; Perretti M
    J Immunol; 2013 Jun; 190(12):6478-87. PubMed ID: 23686496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Esophagoprotective activity of angiotensin-(1-7) in experimental model of acute reflux esophagitis. Evidence for the role of nitric oxide, sensory nerves, hypoxia-inducible factor-1alpha and proinflammatory cytokines.
    Pawlik MW; Kwiecien S; Pajdo R; Ptak-Belowska A; Brzozowski B; Krzysiek-Maczka G; Strzalka M; Konturek SJ; Brzozowski T
    J Physiol Pharmacol; 2014 Dec; 65(6):809-22. PubMed ID: 25554985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The mitochondrion as a key regulator of ischaemic tolerance and injury.
    Silachev DN; Plotnikov EY; Pevzner IB; Zorova LD; Babenko VA; Zorov SD; Popkov VA; Jankauskas SS; Zinchenko VP; Sukhikh GT; Zorov DB
    Heart Lung Circ; 2014 Oct; 23(10):897-904. PubMed ID: 25043581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides.
    Tatro JB
    Neuroimmunomodulation; 1996; 3(5):259-84. PubMed ID: 9218248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential modulation of annexin I binding sites on monocytes and neutrophils.
    Euzger HS; Flower RJ; Goulding NJ; Perretti M
    Mediators Inflamm; 1999; 8(1):53-62. PubMed ID: 10704090
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress.
    Slominski A; Wortsman J; Luger T; Paus R; Solomon S
    Physiol Rev; 2000 Jul; 80(3):979-1020. PubMed ID: 10893429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preconditioning and postconditioning: underlying mechanisms and clinical application.
    Hausenloy DJ; Yellon DM
    Atherosclerosis; 2009 Jun; 204(2):334-41. PubMed ID: 19081095
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proteolytic cleavage of annexin 1 by human leukocyte elastase.
    Rescher U; Goebeler V; Wilbers A; Gerke V
    Biochim Biophys Acta; 2006 Nov; 1763(11):1320-4. PubMed ID: 17023068
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles.
    Kamaly N; Fredman G; Subramanian M; Gadde S; Pesic A; Cheung L; Fayad ZA; Langer R; Tabas I; Farokhzad OC
    Proc Natl Acad Sci U S A; 2013 Apr; 110(16):6506-11. PubMed ID: 23533277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.